When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37311048.
- Also identified by DOI 10.14309/ajg.0000000000002370 and PMC identifier 10898250.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diagnosis of drug-induced liver injury (DILI) is difficult. We reviewed cases in the DILI Network prospective study that were adjudicated to have liver injury due to other causes to discover pearls for improved diagnostic accuracy. Cases were adjudicated by expert opinion and scored from 1 (definite DILI) to 5 (unlikely DILI). Confirmed cases (1-3) were compared with unlikely cases (5). One hundred thirty-four of the 1,916 cases (7%) were unlikely DILI. Alternative diagnoses were autoimmune hepatitis (20%), hepatitis C (20%), bile duct pathology (13%), and hepatitis E (8%). Thorough evaluation, including follow-up, is essential to minimize incorrect diagnosis of idiosyncratic DILI.
Medical subject headings
- Chemical and Drug Induced Liver Injury
- Hepatitis C